ME Therapeutics Holdings Inc.
ME Therapeutics Holdings Inc.
Indice CSE:
CSE25Devise:
CAD ME Therapeutics is an early stage Vancouver based biotechnology company involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. Our main focus is on overcoming the suppressive effects of an important class of immune cells called myeloid cells in order to enhance anti-tumour immunity.
ME Therapeutics Holdings Inc. (METX)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Information d'entreprise
Addresse
177 Robson St.
Vancouver, BC V6B 0N3
CanadaTéléphone
(236) 516-7714Courriel
Info@metherapeutics.comURL
https://www.metherapeutics.comDate d’inscription à la cote
Jeudi, octobre 12, 2023
Agent de transfert
Odyssey Trust CompanySEDAR Information
Type de dossier
Tout
Délai
@count semaine@count mois3 month6 month@count annéeTout le temps
Information d'entreprise
Addresse
177 Robson St.
Vancouver, BC V6B 0N3
CanadaTéléphone
(236) 516-7714Courriel
Info@metherapeutics.comURL
https://www.metherapeutics.comDate d’inscription à la cote
Jeudi, octobre 12, 2023
Agent de transfert
Odyssey Trust CompanyCapitalisation
Capitalisation:
25189438Réservé à l'émission:
12058890Company Officers
Salim Zulifkar Dhanji, Chief Executive Officer
Quinn Martin, Chief Financial Officer
Jamil Kassam, Corporate Secretary
Communiqués de presse
